Literature DB >> 17852031

Hyperthyroidism affects arterial stiffness, plasma NT-pro-B-type natriuretic peptide levels, and subendocardial perfusion in patients with Graves' disease.

Gerd Bodlaj1, Robert Pichler, Walter Brandstätter, Margit Hatzl-Griesenhofer, Wilhelmine Maschek, Georg Biesenbach, Jörg Berg.   

Abstract

BACKGROUND: Arterial stiffness is thought to play a critical role in the pathogenesis of cardiovascular events, and in hyperthyroidism increased cardiovascular event rates have been reported. AIM: To investigate markers of systemic arterial stiffness, volume homeostasis, and subendocardial perfusion and its interrelationship in patients with Graves' disease (GD) in hyperthyroidism and euthyroidism.
METHOD: Aortic augmentation index (AIx@75) as a measure of systemic arterial stiffness and subendocardial viability ratio (SEVR) as a surrogate measure of subendocardial perfusion were assessed by applanation tonometry in 59 patients with GD in hyperthyroidism and euthyroidism, and measurements were compared to plasma levels of NT-pro-B-type natriuretic peptide (NT-ProBNP).
RESULTS: AIx@75 and NT-ProBNP levels were significantly increased in hyperthyroidism compared to euthyroidism and were positively correlated with each other. SEVR was significantly decreased in hyperthyroidism compared to euthyroidism, mainly due to increased heart rates as shown by the heart rate-corrected SEVR75.
CONCLUSIONS: In hyperthyroidism, patients with GD exhibited increased systemic arterial stiffness, paralleled by increased levels of NT-ProBNP, a marker of volume overload. The decreased subendocardial perfusion in hyperthyroidism seemed to be mainly due to increased heart rates. The observed unfavorable hemodynamic alterations in hyperthyroidism may serve to explain increased cardiovascular event rates in patients with GD.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17852031     DOI: 10.1080/07853890701528579

Source DB:  PubMed          Journal:  Ann Med        ISSN: 0785-3890            Impact factor:   4.709


  9 in total

1.  Intra-left ventricular systolic asynchrony in patients with overt hyperthyroidism.

Authors:  Abdulkadir Kırış; Cihangir Erem; Gülhanım Kırış; Mustafa Koçak; Omer Gedikli; Irfan Nuhoğlu; Merih Kutlu; Tuba Kaplan; Mustafa Gökçe; Sükrü Celik
Journal:  Endocrine       Date:  2010-10-23       Impact factor: 3.633

2.  Relationships between serum levels of thyroid hormones and serum concentrations of asymmetric dimethylarginine (ADMA) and N-terminal-pro-B-type natriuretic peptide (NT-proBNP) in patients with Graves' disease.

Authors:  Li-Qun Gu; Lin Zhao; Wei Zhu; Feng-Ying Li; Min-Jia Zhang; Yun Liu; Jian-Min Liu; Guang Ning; Yong-Ju Zhao
Journal:  Endocrine       Date:  2011-03-09       Impact factor: 3.633

Review 3.  Sex differences in mechanisms of arterial stiffness.

Authors:  Jennifer J DuPont; Rachel M Kenney; Ayan R Patel; Iris Z Jaffe
Journal:  Br J Pharmacol       Date:  2019-05-11       Impact factor: 8.739

Review 4.  Cardiovascular involvement in patients with different causes of hyperthyroidism.

Authors:  Bernadette Biondi; George J Kahaly
Journal:  Nat Rev Endocrinol       Date:  2010-06-29       Impact factor: 43.330

Review 5.  Arterial Stiffness in Thyroid and Parathyroid Disease: A Review of Clinical Studies.

Authors:  Andrea Grillo; Vincenzo Barbato; Roberta Maria Antonello; Marco Fabio Cola; Gianfranco Parati; Paolo Salvi; Bruno Fabris; Stella Bernardi
Journal:  J Clin Med       Date:  2022-06-01       Impact factor: 4.964

6.  Serum levels of N-terminal pro-B-type natriuretic peptide are associated with allograft function in recipients of renal transplants.

Authors:  Gerd Bodlaj; Rainer Hubmann; Karim Saleh; Georg Biesenbach; Erich Pohanka; Tatjana Stojakovic; Jörg Berg
Journal:  Wien Klin Wochenschr       Date:  2009       Impact factor: 1.704

Review 7.  Clinical applications of N-terminal pro B-type natriuretic peptide in heart failure and other cardiovascular diseases.

Authors:  Da-Rong Pu; Jun R Chiong; Qi-chang Zhou
Journal:  Heart Fail Rev       Date:  2010-07       Impact factor: 4.214

8.  Aortic stiffness and left ventricular function in patients with differentiated thyroid cancer.

Authors:  A Gazdag; E V Nagy; A Erdei; M Bodor; E Berta; Z Szabó; Z Jenei
Journal:  J Endocrinol Invest       Date:  2014-09-07       Impact factor: 4.256

9.  Arterial Stiffness and Blood Pressure in Patients Newly Diagnosed with Graves' Disease Compared with Euthyroid Controls.

Authors:  Diana Grove-Laugesen; Sofie Malmstroem; Eva Ebbehoj; Anne Lene Riis; Torquil Watt; Lars Rejnmark; Klavs Würgler Hansen
Journal:  Eur Thyroid J       Date:  2020-02-14
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.